| Osteoporosis |
1 |
1 |
| Fractures |
0 |
0.86 |
| Bone |
0 |
0.72 |
| Spinal Fractures and Dislocations |
0 |
0.57 |
| Avascular Necrosis |
0 |
0.56 |
| Bone Density |
0 |
0.56 |
| Metabolic Bone Disorder |
0 |
0.56 |
| Bisphosphonate |
0 |
0.4 |
| Calcium |
0 |
0.15 |
| Chronic Disease |
0 |
0.13 |
| Health Care Quality, Access, and Evaluation |
0 |
0.13 |
| Primary Osteoporosis |
0 |
0.13 |
| Vertebral Fracture |
0 |
0.13 |
| Preventive Screening |
0 |
0.1 |
| Primary Care |
0 |
0.1 |
| Osteoarthritis |
0 |
0.08 |
| Adherence |
0 |
0.07 |
| Breast Cancer |
0 |
0.07 |
| Hip Fracture |
0 |
0.07 |
| Kyphosis |
0 |
0.07 |
| Mobility |
0 |
0.07 |
| Osteoporosis Risk |
0 |
0.07 |
| Patient Safety |
0 |
0.07 |
| Spondylitis, Spondylosis, Kyphosis |
0 |
0.07 |
| Thromboembolism |
0 |
0.07 |
| Tobacco Use |
0 |
0.07 |
| Care and Maintenance of Vision |
0 |
0.06 |
| Hypertension |
0 |
0.06 |
| Social Determinants of Health |
0 |
0.06 |
| ACE Inhibitor |
0 |
0.05 |
| Adverse Effects |
0 |
0.05 |
| Cancer |
0 |
0.05 |
| Cerebrovascular Accident |
0 |
0.05 |
| Estrogen |
0 |
0.05 |
| Exercise |
0 |
0.05 |
| Femur Fracture |
0 |
0.05 |
| Intravenous |
0 |
0.05 |
| Jaw |
0 |
0.05 |
| Lumbar Spine |
0 |
0.05 |
| Metabolism |
0 |
0.05 |
| Osteopenia |
0 |
0.05 |
| Osteosarcoma |
0 |
0.05 |
| Pain |
0 |
0.05 |
| Plain Radiography |
0 |
0.05 |
| Primary Bone Cancer |
0 |
0.05 |
| Tobacco Cessation |
0 |
0.05 |
| Wound Management |
0 |
0.05 |
| Femoral Neck |
0 |
0.04 |
| Myocardial Infarction (MI) |
0 |
0.04 |
| Primary Hyperparathyroidism |
0 |
0.04 |
| Pulmonary Embolism |
0 |
0.04 |
| Treatment Guidelines |
0 |
0.04 |
| A-Scan Biometry |
0 |
0.03 |
| Ankylosing Spondylitis |
0 |
0.03 |
| Arthritis |
0 |
0.03 |
| Blood |
0 |
0.03 |
| Brachial |
0 |
0.03 |
| Breast |
0 |
0.03 |
| Cardiovascular disease |
0 |
0.03 |
| Cervical Region |
0 |
0.03 |
| Child |
0 |
0.03 |
| Clinical Guidelines |
0 |
0.03 |
| Colitis |
0 |
0.03 |
| Depression |
0 |
0.03 |
| Diet |
0 |
0.03 |
| Diuretics |
0 |
0.03 |
| Embolism |
0 |
0.03 |
| Frailty |
0 |
0.03 |
| Gonadotropin-Releasing Hormone (GnRH) Agonists |
0 |
0.03 |
| Hematological Disorders |
0 |
0.03 |
| Hyperparathyroidism |
0 |
0.03 |
| Infarction |
0 |
0.03 |
| Injury |
0 |
0.03 |
| Isolation |
0 |
0.03 |
| Low Testosterone |
0 |
0.03 |
| Minerals |
0 |
0.03 |
| Nutrition |
0 |
0.03 |
| Orbit |
0 |
0.03 |
| Pain Management |
0 |
0.03 |
| Polypharmacy |
0 |
0.03 |
| Professional Societies |
0 |
0.03 |
| Prostate Cancer |
0 |
0.03 |
| Receptors |
0 |
0.03 |
| Sarcoma |
0 |
0.03 |
| Scan |
0 |
0.03 |
| Secondary Osteoporosis |
0 |
0.03 |
| Selective Serotonin-Reuptake Inhibitors (SSRI) |
0 |
0.03 |
| Smoking |
0 |
0.03 |
| Statins |
0 |
0.03 |
| Steroids |
0 |
0.03 |
| Structured Treatment Interruption |
0 |
0.03 |
| Tai Chi |
0 |
0.03 |
| Thrombosis |
0 |
0.03 |
| Thyroid |
0 |
0.03 |
| Thyroid Disease |
0 |
0.03 |
| Vein |
0 |
0.03 |
| Vitamin |
0 |
0.03 |
| X-ray |
0 |
0.03 |
| Deep Venous Thrombosis |
0 |
0.02 |
| Gastroesophageal Reflux Disease |
0 |
0.02 |
| Hyperthyroidism |
0 |
0.02 |
| Lipids Management |
0 |
0.02 |
| Rheumatoid Arthritis |
0 |
0.02 |
| Ulcerative Colitis |
0 |
0.02 |
| Cardiovascular Risk Management |
0 |
0.01 |
| Cataract |
0 |
0.01 |
| Celiac Disease |
0 |
0.01 |
| Complementary and Alternative Medicine |
0 |
0.01 |
| Gastritis |
0 |
0.01 |
| Hypogonadism |
0 |
0.01 |
| Inflammatory Bowel Disease |
0 |
0.01 |
| Menopause |
0 |
0.01 |